New Haven, Conn. — In a new study, Yale School of Medicine (YSM) researchers unveiled a novel diagnostic method for detecting leptospiral virulence-modifying (VM) proteins in the blood and urine of hamsters, an advance that could pave the way for early diagnosis of the tropical disease leptospirosis in humans and improved treatment options. The findings were published in the journal Microbiology Spectrum.

The research, led by Yale’s Dr. Joseph M. Vinetz and his team, in collaboration with Luna Bioscience, a company founded by Vinetz to develop vaccines for emerging global infectious diseases, has led to the development of a monoclonal antibody (mAb)-based capture immunoassay. This assay detects VM proteins, a recently identified family of leptospiral proteins crucial for disease pathogenesis.

Saudi German Health (SGH), a leading healthcare provider and pioneer in advancing medical excellence across the region, today announced a major expansion of its relationship with Mayo Clinic. This milestone cements SGH as the largest group of Mayo Clinic Care Network members in the region, bringing world-class expertise and innovation closer to patients across the Kingdom and beyond.

Beyond the sneezing and itchy eyes, high pollen seasons are now linked to a significant increase in suicide risk.